YOLFTbeta
Vitasora Health Ltd

Vitasora Health Ltd

VHL · AU · Healthcare / Health Information Services

0.011AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.011
Open0.011
Day Range0.01 – 0.011
52-Week Range0.009 – 0.039
Volume2.17M
Market Cap28.18M
P/E (TTM)0.00
Forward P/E0.93
EPS-0.01
Dividend Yield0.00%
Beta-0.32
50-Day Avg0.0125
200-Day Avg0.0166

About

Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Marjan Mikel B.Sc., M.A.I.C.D.
  • Employees0
  • Headquarters432 St Kilda Road, Melbourne, VIC, Australia, 3004, Australia
  • Websitehttps://vitasorahealth.com.au

Leadership

  • Mr. Marjan Mikel B.Sc., M.A.I.C.D.CEO, MD & Executive Director
  • Dr. Samaneh Sarraf ShiraziChief Research Officer
  • Mr. William SigsbeeHead of US Operations & Chief Commercial Officer for the US market
  • Mr. Tony Di PietroCompany Secretary
  • Prof. Noam Gavriely D.Sc., M.D.Medical & Scientific Advisor
  • Mr. Simon Godfrey FRCP, FRCPCH, M.D., Ph.D.Medical & Scientific Advisor

Financials

Income Statement

Currency: AUD1997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue1.74M---49.00K50.75K2.90K---149.16K100.19K225.43K348.49K332.09K12.97K10.86K18.98K93.99K677.75K825.60K861.46K1.03M2.16M270.07K253.69K70.53K456.91K3.71M4.28M
Growth (%)-----+3.57%-94.29%-----32.83%+125.00%+54.59%-4.71%-96.09%-16.26%+74.74%+395.33%+621.11%+21.81%+4.34%+19.13%+110.02%-87.47%-6.07%-72.20%+547.80%+710.91%+15.40%
Cost of Revenue----4.77B1.71M571.38K-----294.95K269.89K239.77K16.98K152.99K--1.36M294.97K125.45K4.63K10.38K2.53M2.15M2.52M3.86K29.91K10.15M
Gross Profit1.74M---49.00K-1.66M-568.48K---149.16K100.19K-69.52K78.61K92.32K-4.01K-142.13K18.98K93.99K-686.18K530.63K736.01K1.02M2.14M-2.26M-1.90M-2.45M453.06K3.68M-5.87M
Gross Margin100.00%---100.00%-3276.76%-19602.83%---100.00%100.00%-30.84%22.56%27.80%-30.92%-1308.91%100.00%100.00%-101.24%64.27%85.44%99.55%99.52%-836.72%-747.68%-3468.34%99.16%99.19%-137.33%
Operating Expense0---236.00K10.48M4.11M---3.73M12.61M6.82M6.20M6.90M5.50M5.67M11.24M5.59M3.33M3.89M4.82M10.53M11.61M9.90M5.25M3.91M8.10M13.78M5.30M
Operating Income1.74M-714.43K-1.80M-5.85M-187.00K-12.15M-4.68M----3.58M-12.51M-6.89M-6.12M-6.80M-5.50M-5.82M-11.22M-5.50M-4.02M-3.36M-4.09M-9.51M-9.46M-12.16M-7.15M-6.35M-7.65M-10.10M-11.17M
Operating Margin100.00%----381.63%-23933.89%-161220.14%----2403.30%-12485.13%-3056.81%-1757.38%-2048.86%-42438.20%-53559.76%-59144.20%-5848.58%-592.70%-406.84%-474.66%-926.28%-439.04%-4503.18%-2818.30%-9005.52%-1673.36%-272.69%-261.35%
EBITDA1.74M-714.43K-1.80M-5.85M-8.67M-11.55M-4.16M-833.91K-742.18K-368.83K-3.56M-12.33M-6.62M-5.87M-6.58M-5.13M-5.44M-10.98M-5.25M-3.78M-3.05M-3.94M-9.50M-9.41M-11.95M-7.04M-5.68M-7.00M-10.66M-9.92M
EBITDA Margin100.00%----17690.84%-22758.22%-143556.34%----2386.16%-12307.77%-2938.35%-1684.23%-1981.70%-39536.36%-50119.33%-57855.11%-5583.94%-558.44%-369.75%-457.74%-925.33%-436.40%-4423.77%-2774.69%-8057.22%-1532.06%-287.59%-232.05%
Net Income256.08K-311.03K-912.09K-6.09M-8.70M-11.86M-4.29M-225.45K-724.19K-1.19M-5.12M-11.68M-6.70M-5.94M-6.68M-5.59M-5.58M-10.31M-5.46M-4.01M-2.52M-3.21M-8.47M-7.26M-11.04M-6.62M-5.78M-7.13M-10.11M-10.61M
Net Income Margin14.70%----17744.90%-23375.30%-148036.76%----3435.56%-11655.79%-2972.56%-1704.41%-2010.71%-43068.88%-51419.55%-54334.42%-5813.98%-591.80%-305.48%-372.30%-825.78%-336.89%-4087.90%-2611.20%-8188.07%-1560.30%-272.73%-248.15%
R&D-----2.49M----1.32M3.02M583.37K242.27K181.71K1.52M2.16M3.84M3.05M1.31M1.12M1.51M4.24M2.04M1.39M1.46M377.73K137.13K241.40K383.64K
R&D as % of Total Revenue-----4915.00%----884.50%3015.37%258.78%69.52%54.72%11706.62%19851.67%20243.56%3249.72%193.39%136.25%175.55%412.90%94.44%513.59%576.83%535.53%30.01%6.52%8.97%
Interest Expense---191.00K26.49K21.08K2.43K--------192.24K33.50K---------15.00K65.02K--
Interest Expense % of Total Revenue----54.06%41.53%83.69%--------1482.40%308.49%---------21.27%14.23%--

Balance Sheet

Currency: AUD1997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets--17.06M10.31M14.88M2.54M559.54K1.30M1.59M422.38K3.05M5.77M5.10M4.60M3.35M3.11M2.84M10.60M5.18M5.08M2.64M2.66M1.01M4.62M9.11M4.21M3.18M6.19M18.40M18.84M
Total Liabilities--1.12M2.71M1.60M1.16M1.51M162.69K80.98K34.02K646.75K914.92K1.17M1.73M1.24M998.39K1.22M1.53M1.28M1.04M843.65K1.01M2.58M2.12M1.54M1.20M2.35M3.55M3.74M2.71M
Total Equity--15.94M7.60M13.28M1.38M-949.92K1.14M1.51M388.37K2.41M4.85M3.93M2.87M2.11M2.11M1.62M9.08M3.90M4.04M1.80M1.65M-1.56M2.49M7.57M3.01M826.89K2.64M14.67M16.13M
Cash--16.37M8.04M12.42M1.14M376.09K1.30M1.08M415.26K588.52K3.37M2.96M2.30M1.31M1.33M1.35M8.21M3.01M4.50M1.56M2.42M306.65K3.55M7.97M1.22M146.16K762.87K394.24K3.06M
Total Debt--180.47K68.00K28.17K17.00K------323.82K44.94K-2.90K------806.44K892.88K142.47K70.66K149.13K1.29M--
Net Debt---16.19M-7.97M-12.39M-1.13M-376.09K-1.30M-1.08M-415.26K-588.52K-3.37M-2.64M-2.25M-1.31M-1.33M-1.35M-8.21M-3.01M-4.50M-1.56M-2.42M499.79K-2.66M-7.83M-1.15M2.97K530.09K--3.06M

Cash Flow

Currency: AUD1997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow150.84K----9.17M-11.18M--620.94K-798.42K-656.61K-2.29M-5.80M-3.50M-5.12M-5.35M-4.88M-4.94M-9.10M-5.89M-2.39M-2.93M-2.08M-6.41M-4.69M-7.34M-8.48M-4.49M-6.64M-9.17M-10.00M
Investing Cash Flow-2.40K-5.03K-22.51K-217.00K-1.07M-114.00K7.23K-620.94K-1.43K-855-269.53K-121.75K-11.87K-157.80K-23.06K-32-17.60K-104.28K-14.96K-18.39K13.53K-6.50K-3.18K-12.86K-54.25K-2.27K-21.80K-1.89M1.13M-490.46K
Financing Cash Flow-10.00K3.58M10.17M14.62M15.00K1.95M1.92M579.34K-3.46K2.78M8.70M3.09M4.52M4.39M4.90M4.77M16.09M29.14K3.96M-2.95M4.33M7.96M11.79M1.64M3.46M9.13M7.66M13.25M
Capital Expenditure2.40K5.03K22.51K217.00K1.07M183.00K001.83K855191.85K121.75K11.87K159.94K26.00K2.28K17.60K71.47K17.35K18.39K5827.90K3.18K12.86K54.25K2.27K21.80K004
Free Cash Flow148.43K-5.03K-22.51K-217.00K-10.24M-11.36M--620.94K-800.25K-657.47K-2.48M-5.92M-3.51M-5.28M-5.38M-4.88M-4.95M-9.17M-5.91M-2.41M-2.93M-2.08M-6.41M-4.70M-7.39M-8.48M-4.51M-6.64M-9.17M-10.00M
FCF to OCF98.41%---111.66%101.64%-100.00%100.23%100.13%108.38%102.10%100.34%103.12%100.49%100.05%100.36%100.79%100.29%100.77%100.02%100.38%100.05%100.27%100.74%100.03%100.49%100.00%100.00%100.00%

Earnings

Report DateFeb 29, 2016Aug 31, 2016Feb 27, 2017Aug 30, 2017Feb 26, 2018Aug 31, 2018Feb 26, 2019Aug 28, 2019Feb 19, 2020Aug 25, 2020Feb 19, 2021Aug 27, 2021Feb 21, 2022Aug 31, 2022Feb 27, 2023Feb 26, 2025Aug 27, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.010.000.000.000.00-0.01-0.01-0.010.00-0.01-0.01-0.010.000.000.000.000.00
Surprise-----------------
Timing-----------------

Key Statistics & Ratios

Market Cap28.18M
Enterprise Value25.11M
Trailing P/E0.00
Forward P/E0.93
Price / Sales5.82
Price / Book1.75
EPS-0.01
Book Value0.007
Revenue (TTM)4.84M
Gross Profit (TTM)4.26M
EBITDA-9.36M
Profit Margin-219.22%
Operating Margin-275.42%
Return on Equity-70.26%
Return on Assets-36.19%
Shares Outstanding2.35B
Shares Float1.60B
Beta-0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 31, 20121:20
  • Nov 29, 20041:25
  • Aug 19, 20031:2